Silence Therapeutics plc (SLN)
NASDAQ: SLN · IEX Real-Time Price · USD
20.99
-0.03 (-0.14%)
At close: Jul 26, 2024, 4:00 PM
21.00
+0.01 (0.05%)
After-hours: Jul 26, 2024, 7:46 PM EDT
Silence Therapeutics Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2013 |
|---|---|---|---|---|---|---|---|
| Revenue | 26.41 | 25.38 | 17.5 | 12.42 | 5.48 | 0.24 | Upgrade
|
| Revenue Growth (YoY) | 14.05% | 44.99% | 40.97% | 126.59% | 2145.49% | - | Upgrade
|
| Cost of Revenue | 8 | 10.32 | 10.88 | 7.46 | 3.76 | - | Upgrade
|
| Gross Profit | 18.41 | 15.06 | 6.62 | 4.96 | 1.72 | 0.24 | Upgrade
|
| Selling, General & Admin | 19.36 | 20.64 | 19.61 | 20.01 | 13.98 | 9.64 | Upgrade
|
| Research & Development | 40.67 | 44.03 | 35.61 | 30.77 | 20.21 | 13.34 | Upgrade
|
| Other Operating Expenses | - | - | - | - | -1.49 | - | Upgrade
|
| Operating Expenses | 60.02 | 64.66 | 55.21 | 50.77 | 32.7 | 22.98 | Upgrade
|
| Operating Income | -41.61 | -49.6 | -48.59 | -45.81 | -30.98 | -22.73 | Upgrade
|
| Interest Expense | - | -0.03 | -0.05 | -0.01 | -0.02 | -0.03 | Upgrade
|
| Interest & Investment Income | 1.35 | 0.07 | 0.02 | 0.01 | 0.13 | 0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | -2.12 | -2.12 | 1.05 | -0.04 | -5.17 | -0.13 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.38 | 1.38 | 0.2 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -41 | -50.31 | -47.37 | -45.86 | -36.04 | -22.87 | Upgrade
|
| Pretax Income | -41 | -50.31 | -47.37 | -45.86 | -36.04 | -22.87 | Upgrade
|
| Income Tax Expense | -6.06 | -7.04 | -6.88 | -6.45 | -3.49 | -3.29 | Upgrade
|
| Net Income | -34.94 | -43.27 | -40.49 | -39.41 | -32.55 | -19.58 | Upgrade
|
| Net Income to Common | -34.94 | -43.27 | -40.49 | -39.41 | -32.55 | -19.58 | Upgrade
|
| Shares Outstanding (Basic) | 39 | 37 | 32 | 30 | 27 | 25 | Upgrade
|
| Shares Outstanding (Diluted) | 39 | 37 | 32 | 30 | 27 | 25 | Upgrade
|
| Shares Change (YoY) | 15.96% | 15.21% | 8.58% | 8.78% | 8.85% | 6.85% | Upgrade
|
| EPS (Basic) | -0.89 | -1.17 | -1.26 | -1.33 | -1.19 | -0.78 | Upgrade
|
| EPS (Diluted) | -0.89 | -1.17 | -1.26 | -1.33 | -1.19 | -0.78 | Upgrade
|
| Free Cash Flow | -39.21 | -39.4 | -45.6 | 5.5 | -11.29 | 1.72 | Upgrade
|
| Free Cash Flow Per Share | -1.00 | -1.06 | -1.42 | 0.19 | -0.41 | 0.07 | Upgrade
|
| Gross Margin | 69.72% | 59.34% | 37.83% | 39.94% | 31.34% | 100.00% | Upgrade
|
| Operating Margin | -157.58% | -195.48% | -277.66% | -369.02% | -565.49% | -9317.21% | Upgrade
|
| Profit Margin | -132.31% | -170.51% | -231.35% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -148.47% | -155.25% | -260.53% | 44.26% | -206.00% | 704.10% | Upgrade
|
| EBITDA | -41.29 | -49.27 | -48.28 | -45.56 | -30.49 | -22.25 | Upgrade
|
| EBITDA Margin | -156.37% | -194.18% | -275.89% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.32 | 0.33 | 0.31 | 0.25 | 0.5 | 0.48 | Upgrade
|
| EBIT | -41.61 | -49.6 | -48.59 | -45.81 | -30.98 | -22.73 | Upgrade
|
| EBIT Margin | -157.58% | -195.48% | -277.66% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template.